SecBot SecBot

MRVI

MARAVAI LIFESCIENCES HOLDINGS, INC.
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001823239 Biotech & Drug Discovery
$7.40 −0.14 (−1.86%)
Nov 16 4:00 PM ET · prev $7.54
Market cap
$2.0B
Small cap
Consensus
Buy
67% Buy or better · 15 analysts
Median target
$9.50
+28% · range $8.00–12.00
1 year
+121.6%
from $3.34 · Nov 17
30 days
+5.9%
from $6.99
52-week range
$2.83–9.00
−18% from high · low Mar 31
Avg volume 20D
2.21M
shares / day
Short interest
14.05M
≈5.4% of shares · +5.3%
Days to cover
6.8
at average volume
Insider net
−$254.0K
0 buyers · 1 seller · 12 mo
New fund stakes
2
Q3 2026 13F · 0 exits
Filing reports
5
analyzed by SecBot
SecBot read MIXED 1 report · 90 days
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/1

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    1 insider sold $254.0K.

  • InstitutionsBULLISH

    Q3 2026: 30 added (2 new), 10 trimmed or exited.

  • AnalystsBULLISH

    10 of 15 rate it Buy or better. Every target is above the price.

  • EstimatesRISING

    Current-quarter EPS estimate −$0.084 → −$0.039 over 90 days. 1 up, 0 down in 30 days.

  • Short sellersSTEADY

    Short interest +5.3% to 14.05M shares. 6.8 days to cover, ≈5.4% of shares.

  • TrendUPTREND

    0% above its 50-day average.

Who's buying

13F· Q3 2026
2
new positions
0
exits
FundMoveSharesValue
FMR LLCDOUBLED6,900,420$52.9M
Qube Research & Technologies LtdDOUBLED2,911,005$22.3M
MORGAN STANLEYADD2,711,057$20.8M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPADD2,490,438$19.1M
MARSHALL WACE, LLPADD2,034,070$15.6M
BNP PARIBAS FINANCIAL MARKETSADD1,413,405$10.8M
HRT FINANCIAL LPADD1,371,328$10.5M
JPMORGAN CHASE & CONEAR_EXIT446,410$3.4M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

15 analysts
Buy 67% rate it Buy or better
Strong Buy4Buy6Hold5Sell0Strong Sell0
12-month targets · 7 analysts

Price is below the lowest target. Median implies +28%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 12, 2026Keybanc
UPGRADE
UPGRADEOverweight
Sep 9, 2026UBS
MAINTAIN
MAINTAINNeutral
Aug 7, 2026Wells Fargo
MAINTAIN
MAINTAINOverweight

Insider ledger

Form 4
$0
bought · 0 insiders
$254.0K
sold · 1 insider
DateInsiderTypeValue
Nov 9, 2026
Brust Bernd
Chief Executive Officer
Nov 9, 2026
TAX W/H$220.0K
Oct 30, 2026
Asarpota Rajesh
Chief Financial Officer
Oct 30, 2026
TAX W/H$46.2K
Oct 8, 2026
Brust Bernd
Chief Executive Officer
Oct 8, 2026
TAX W/H$217.3K
Sep 30, 2026
Asarpota Rajesh
Chief Financial Officer
Sep 30, 2026
TAX W/H$41.8K
Sep 8, 2026
Brust Bernd
Chief Executive Officer
Sep 8, 2026
TAX W/H$214.1K
Aug 31, 2026
Asarpota Rajesh
Chief Financial Officer
Aug 31, 2026
TAX W/H$42.0K
Aug 10, 2026
Brust Bernd
Chief Executive Officer
Aug 10, 2026
TAX W/H$182.2K
Jul 30, 2026
Asarpota Rajesh
Chief Financial Officer
Jul 30, 2026
TAX W/H$36.0K

Earnings setup

Estimates
−$0.04
EPS estimate, this quarter
+54%
estimate change, 90 days
1↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.04-$0.06–-$0.02+12.3%$51.2M
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 30, 2026
14,053,895
shares short
+5.3%
vs prior settlement
6.8
days to cover
≈5.4%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 9, 2026 Insider
Brust Bernd surrendered for taxes 29,250 shares
Chief Executive Officer @ $7.52 ($220.0K)
Nov 4, 2026 Earnings result
MRVI Q3 2026 Earnings: EPS $-0.03 (+48.1% vs est)
Oct 30, 2026 Insider
Asarpota Rajesh surrendered for taxes 5,466 shares
Chief Financial Officer @ $8.46 ($46.2K)
Oct 8, 2026 Insider
Brust Bernd surrendered for taxes 29,250 shares
Chief Executive Officer @ $7.43 ($217.3K)
Sep 30, 2026 Inst.
FMR LLC · DOUBLED
6,900,420 shares ($52.9M)
Sep 30, 2026 Inst.
Qube Research & Technologies · DOUBLED
2,911,005 shares ($22.3M)
Sep 29, 2026 SEC
Millennium Management LLC filed a Schedule 13G disclosing a 5.2% passive stake in Maravai LifeSciences Holdings, Inc…
SC 13G · Impact 4/10
Jun 14, 2026 SEC
During Q1 2026, six institutional investors increased their MRVI positions (net +$2.3M) while three trimmed (net…
INST-CLUSTER · Impact 4/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

5 filings · 1 bullish · 0 bearish · 2 mixed · 2 neutral
All MRVI filing & press-release reports (5)